THE CLINICAL COURSE OF ATRIAL FIBRILLATION IN PATIENTS WITH CORONARY HEART DISEASE
Keywords:
coronary heart disease, persistent form of atrial fibrillation, progression factorsAbstract
Atrial fibrillation (AF) is one of the most common cardiac arrhythmias, with a frequency in the general population of 2% and continues to increase. AF affects the quality of life of patients and reduces life expectancy. AF is believed to be an independent risk factor for cardiovascular disease. According to the latest recommendations for the diagnosis and treatment of AF, there are 5 types of arrhythmias: first detected, paroxysmal, persistent, prolonged persistent and persistent. The majority of patients with AF progresses to a persistent or permanent form, leading to a worsening of the clinical picture of patients and their prognosis.
References
Guidelines for management of atrial fibrillation. The task force for the management of atrial fibrillation of European Society of Cardiology (ESC). Eur. Heart J. 2013; 31(19): 2369-439.
Nabauer M., Gerth A., Limbourg T. et al. The Registry of the German Competence NET work on Atrial Fibrillation: patient characteristics and initial management. Europace 2009; 11: 423—34.
Nieuwlaat R., Capucci A., Camm A.J. et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005; 26: 2422—34.
De Vos C.B., Pisters R., Nieuwlaat R. et al. Progression from paroxysmal to persistent atrial fibrillation. J. Am. Coll. Cardiol. 2010; 55(8): 725—31.
Holmqvist F., Kim S., Steinberg B.A. et al. Heart rate is associated with progression of atrial fibrillation, independent of rhythm. Heart, 2015; 101: 894—9.
Im S.I., Chun K.J., Park S.J. et al. Long-term prognosis of paroxysmal atrial fibrillation and predictors for progression to persistnt or chronic atrial fibrillation in the Korean population. J. Korean Med. Sci. 2015; 30(7): 895—902.
Rizaeva, M. Z. (2022). The clinical course of atrial fibrillation in patients with coronary heart disease. European journal of molecular medicine, 2(1).
Rizaeva, M. Z. (2022). Efficiency and safety of electric cardioversion in persistent form of atrial fibrillation. European journal of molecular medicine, 2(5).
Пулатова, Ш. Х. (2023). A new approach to the treatment of type 2 diabetes mellitus with coronary heart disease. Узбекский медицинский журнал, (SI-1).
Ризаева, М. Ж. (2023). Трудности Свертывающей Системы У Больных С Фибрилляции Предсердий (Обзорная Статья). Miasto Przyszłości, 36, 465-469.
Sh, A. N., & Rizaeva, M. J. (2023). Problems of hemostasis in patients with persistent atrial fibrillation on the background of coronary heart disease. Eurasian Research Bulletin, 21, 1-6.
Пулатова, Ш. Х. (2012). Учредители: Институт иммунологии Академии Наук Республики Узбекистан. Теоретической и клинической медицины Учредители: Институт иммунологии Академии Наук Республики Узбекистан ISSN: 2091-5853
